
Jacopo Fanizza
Articles
-
Aug 23, 2024 |
mdpi.com | Jacopo Fanizza |Sarah Bencardino |Mariangela Allocca |Federica Furfaro
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
-
Aug 13, 2024 |
mdpi.com | Ilaria Faggiani |Jacopo Fanizza |Ferdinando D’Amico |Mariangela Allocca
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
-
Jul 31, 2024 |
preprints.org | Jacopo Fanizza |Sarah Bencardino |Mariangela Allocca |Federica Furfaro
PreprintReviewVersion 1This version is not peer-reviewedVersion 1: Received: 31 July 2024 / Approved: 31 July 2024 / Online: 31 July 2024 (12:01:23 CEST)Fanizza, J.; Bencardino, S.; Allocca, M.; Furfaro, F.; Zilli, A.; Parigi, T. L.; Fiorino, G.; Peyrin-Biroulet, L.; Danese, S.; D’Amico, F. Inflammatory Bowel Disease and Colorectal Cancer. Preprints 2024, 2024072568. https://doi.org/10.20944/preprints202407.2568.v1Fanizza, J.; Bencardino, S.; Allocca, M.; Furfaro, F.; Zilli, A.; Parigi, T.
-
Dec 30, 2023 |
mdpi.com | Jacopo Fanizza |Ferdinando D’Amico |Francesca Lusetti |Ernesto Fasulo
All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.
-
Nov 27, 2023 |
futuremedicine.com | Jacopo Fanizza |Ferdinando D’Amico |Gaetano Lauri |Samuel J. Martínez-Domínguez
M Allocca received consulting fees from Nikkiso Europe, Mundipharma, Janssen, Abbvie and Pfizer. F Furfaro received consulting fees from Amgen and Abbvie and lecture fees from Janssen and Pfizer. G Fiorino received consultancy fees from Ferring, MSD, AbbVie, Takeda, Janssen, Amgen, Sandoz, Samsung Bioepis and Celltrion.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →